Analisis Ketepatan Waktu Pengiriman Sampel Sputum di Upt Puskesmas Pangala
Inovasi Kesehatan Global · 18.05.2026 · 3 (2) · 147-157
DOI: 10.62383/ikg.v3i2.3047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inovasi Kesehatan Global, online erschienen am 18.05.2026. Verfasst von Norma Oknita und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
tuberculosis (TB) is one of the oldest infectious diseases that has been present throughout human history and remains a significant public health problem worldwide today. Technological developments have enabled TB detection using the GeneXpert® MTB/RIF Molecular Rapid Test (TCM). Fast and accurate laboratory testing is essential in healthcare services. This study aims to analyze the timeliness of sputum sample delivery at the Pangala Community Health Center (UPT Puskesmas Pangala), using a qualitative research design, namely a descriptive type of research by observing sputum samples stored at the Pangala Community Health Center (UPT Puskesmas Pangala) before being sent to the reference laboratory. The sample in this study was 36 samples taken by total sampling. The results showed that there were 29 samples sent within a period of
Zitieren
APA
Oknita, N., Cahyani, A. A. A. E., Subhaktiyasa, P. G., & Idayani, S. (2026). Analisis Ketepatan Waktu Pengiriman Sampel Sputum di Upt Puskesmas Pangala. Inovasi Kesehatan Global, 3(2), 147-157. https://doi.org/10.62383/ikg.v3i2.3047
Vancouver
Oknita N, Cahyani AAAE, Subhaktiyasa PG, Idayani S. Analisis Ketepatan Waktu Pengiriman Sampel Sputum di Upt Puskesmas Pangala. Inovasi Kesehatan Global. 2026;3(2):147-157. doi:10.62383/ikg.v3i2.3047
BibTeX
@article{Oknita2026,
author = {Oknita, Norma and Cahyani, Ana Agung Ayu Eka and Subhaktiyasa, Putu Gede and Idayani, Sri},
title = {Analisis Ketepatan Waktu Pengiriman Sampel Sputum di Upt Puskesmas Pangala},
journal = {Inovasi Kesehatan Global},
year = {2026},
volume = {3},
number = {2},
pages = {147--157},
doi = {10.62383/ikg.v3i2.3047}
}
EUVIMED